Key Market Indicators
Sales of Greek blood and blood forming organs medicine are projected to reach $1.02 billion by 2026. This is up from $934.5 million in 2021, representing an average year-on-year growth rate of 0.7%. Since 1995, the Greek market has decreased by an average of 13.1% year-on-year. Greece was ranked eighth in 2021, with Canada coming in ahead at $934.5 million. Germany, Italy and South Korea respectively came in second, third and fourth in the same ranking.